Pharmacokinetics and Relative Bioavailability Study
Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
A Single-Dose Pharmacokinetics And Relative Bioavailability Study Of Tolterodine From Two
Microspheres In Powder Blend Extended Release Formulations Compared To The Commercial
Extended Release Capsules
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.